| Casey Brooke Hill, FNP | |
|
632 Lakeland East Dr Ste B, Flowood, MS 39232-9565 | |
| (769) 243-6141 | |
| Not Available |
| Full Name | Casey Brooke Hill |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 632 Lakeland East Dr Ste B, Flowood, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477137065 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 904212 (Mississippi) | Primary |
| Entity Name | Wound Management Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972150084 PECOS PAC ID: 5193056364 Enrollment ID: O20191021000339 |
News Archive
Align Networks, Inc., a leading provider of workers' compensation physical medicine programs, and Universal SmartComp, a nationwide provider of physical medicine services, today announced that they have closed their previously announced merger.
The provision of long-term care in the U.S. has shifted from what was once a predominantly institutionally based system of care to one in which recipients can increasingly receive a range of both medical and supportive services at home and in the community, according to the latest edition of The Gerontological Society of America's Public Policy & Aging Report.
The scientific cooperation between chemists, biotechnologists and physicists from various Catalan institutes, headed by Pau Gorostiza, from the Institute for Bioengineering of Catalonia (IBEC), and Ernest Giralt, from the Institute for Research in Biomedicine (IRB Barcelona), has led to a breakthrough that will favor the development of light-regulated therapeutic molecules.
Vanda Pharmaceuticals Inc. announced today that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. Food and Drug Administration on May 6, 2009 for the acute treatment of schizophrenia in adults.
› Verified 5 days ago
| Entity Name | Progressive Medical Management Of Batesville Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700349222 PECOS PAC ID: 0345583225 Enrollment ID: O20191114002265 |
News Archive
Align Networks, Inc., a leading provider of workers' compensation physical medicine programs, and Universal SmartComp, a nationwide provider of physical medicine services, today announced that they have closed their previously announced merger.
The provision of long-term care in the U.S. has shifted from what was once a predominantly institutionally based system of care to one in which recipients can increasingly receive a range of both medical and supportive services at home and in the community, according to the latest edition of The Gerontological Society of America's Public Policy & Aging Report.
The scientific cooperation between chemists, biotechnologists and physicists from various Catalan institutes, headed by Pau Gorostiza, from the Institute for Bioengineering of Catalonia (IBEC), and Ernest Giralt, from the Institute for Research in Biomedicine (IRB Barcelona), has led to a breakthrough that will favor the development of light-regulated therapeutic molecules.
Vanda Pharmaceuticals Inc. announced today that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. Food and Drug Administration on May 6, 2009 for the acute treatment of schizophrenia in adults.
› Verified 5 days ago
| Entity Name | H&b Mission Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568238889 PECOS PAC ID: 9234572447 Enrollment ID: O20240205002614 |
News Archive
Align Networks, Inc., a leading provider of workers' compensation physical medicine programs, and Universal SmartComp, a nationwide provider of physical medicine services, today announced that they have closed their previously announced merger.
The provision of long-term care in the U.S. has shifted from what was once a predominantly institutionally based system of care to one in which recipients can increasingly receive a range of both medical and supportive services at home and in the community, according to the latest edition of The Gerontological Society of America's Public Policy & Aging Report.
The scientific cooperation between chemists, biotechnologists and physicists from various Catalan institutes, headed by Pau Gorostiza, from the Institute for Bioengineering of Catalonia (IBEC), and Ernest Giralt, from the Institute for Research in Biomedicine (IRB Barcelona), has led to a breakthrough that will favor the development of light-regulated therapeutic molecules.
Vanda Pharmaceuticals Inc. announced today that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. Food and Drug Administration on May 6, 2009 for the acute treatment of schizophrenia in adults.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Casey Brooke Hill, FNP 163 Mandarin Dr, Brandon, MS 39047-7336 Ph: (601) 842-6545 | Casey Brooke Hill, FNP 632 Lakeland East Dr Ste B, Flowood, MS 39232-9565 Ph: (769) 243-6141 |
News Archive
Align Networks, Inc., a leading provider of workers' compensation physical medicine programs, and Universal SmartComp, a nationwide provider of physical medicine services, today announced that they have closed their previously announced merger.
The provision of long-term care in the U.S. has shifted from what was once a predominantly institutionally based system of care to one in which recipients can increasingly receive a range of both medical and supportive services at home and in the community, according to the latest edition of The Gerontological Society of America's Public Policy & Aging Report.
The scientific cooperation between chemists, biotechnologists and physicists from various Catalan institutes, headed by Pau Gorostiza, from the Institute for Bioengineering of Catalonia (IBEC), and Ernest Giralt, from the Institute for Research in Biomedicine (IRB Barcelona), has led to a breakthrough that will favor the development of light-regulated therapeutic molecules.
Vanda Pharmaceuticals Inc. announced today that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. Food and Drug Administration on May 6, 2009 for the acute treatment of schizophrenia in adults.
› Verified 5 days ago
Hannah Ray, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2466 Flowood Dr, Flowood, MS 39232 Phone: 601-815-5700 Fax: 601-815-5795 | |
Anuj Marya, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 Katherine Dr Ste A, Flowood, MS 39232 Phone: 601-665-4162 Fax: 855-830-3484 | |
Dr. Susan Frichter Williams, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 151 E Metro Dr Ste 103, Flowood, MS 39232 Phone: 601-992-3288 Fax: 601-992-3188 | |
Kimyuana Jackson Dorris, PMHNP, AGNP-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 215 Katherine Dr Ste A, Flowood, MS 39232 Phone: 601-665-4162 Fax: 888-398-1151 | |
Alana Piersanti, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2466 Flowood Dr, Flowood, MS 39232 Phone: 601-815-5700 Fax: 601-815-5795 | |
Dr. Kevin Michael Young, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Layfair Dr, Suite 100, Flowood, MS 39232 Phone: 601-939-4008 | |
Christopher D. Boston, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 294 E Layfair Dr, Flowood, MS 39232 Phone: 601-414-6520 |